Introduction: New antipsychotics continuously arrive on the market, which thereby influences
the approved and off-label prescribing (OLP) schemes. We aimed to identify the recent …

Background Multimorbidity is increasingly prevalent and represents a major challenge in
primary care. Patients with multimorbidity are potentially more likely to experience safety …

Importance Off-label use of prescription drugs has been identified as an important
contributor to preventable adverse drug events (ADEs) in children. Despite concerns …

Objective To examine off-label indications for antidepressants in primary care and determine
the level of scientific support for off-label prescribing. Design Descriptive study of …

Institutional corruption is a normative concept of growing importance that embodies the
systemic dependencies and informal practices that distort an institution's societal mission …

The prescribed use of pharmaceuticals can result in unintended, unwelcomed, and
potentially adverse consequences for the environment and for those not initially targeted for …

Psychiatric drugs have primacy for off-label prescribing. Among those, selective serotonin
reuptake inhibitors (SSRIs) are highly versatile and, therefore, widely prescribed. Moreover …

Second–generation antipsychotics (SGAPs) and second–generation antidepressants
(SGADs) have multiple US Food and Drug Administration–approved indications and are …

Off-label prescribing of psychiatric drugs is common, despite lacking strong scientific
evidence of efficacy and potentially increasing risk for adverse events. The goal of this study …

Background People with intellectual disability (ID) frequently use antipsychotic drugs on an
off‐label base, often for many years. Physicians' decisions to discontinue these drugs not …